Skip to main content
. 2011 May 11;96(7):2154–2162. doi: 10.1210/jc.2010-2964

Fig. 3.

Fig. 3.

HLA-DRB1, HLA-DQB1, and HLA-B were evaluated in AD individuals (including 21-hydroxylase positive progressors), 21-hydroxylase-positive individuals who have not progressed to AD [21-OH+(NP)], and patients with T1DM (DM). A, Percent HLA-B15 in all subjects genotyped for the aforementioned loci. B. Percent HLA-B15 in only the HLA-DR4 positive subjects. All P values listed are relative to AD.